Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Pig stem cell research conducted by two animal scientists at the University of Georgia reveals a better way to determine the safety of future stem cell therapies than rodent-based models.
Rodent studies are likely inadequate for testing many human therapies -- including pharmaceuticals -- since 50 percent of all chemicals test positive as carcinogens in rodents regardless of their source or identity, according to Thomas Hartung, a professor in the Bloomsburg College of Public Health at Johns Hopkins University. He suggests these rodent studies may be no better than a coin toss. For example, some components in coffee appear to be carcinogenic in rodents, but in humans moderate coffee consumption may reduce the risk of cancer.
http://www.sciencedaily.com/releases/2011/12/111209171942.htm
Rodent studies are likely inadequate for testing many human therapies -- including pharmaceuticals -- since 50 percent of all chemicals test positive as carcinogens in rodents regardless of their source or identity, according to Thomas Hartung, a professor in the Bloomsburg College of Public Health at Johns Hopkins University. He suggests these rodent studies may be no better than a coin toss. For example, some components in coffee appear to be carcinogenic in rodents, but in humans moderate coffee consumption may reduce the risk of cancer.
http://www.sciencedaily.com/releases/2011/12/111209171942.htm
